InvestorsHub Logo
icon url

marzan

08/24/19 11:41 AM

#240947 RE: hyperopia #240944

Did you guys notice, the Acting FDA Commish did not mention anything about the phony helmet. He knows it is a sham. Otherwise he would have touched upon the devices. He decided the already approved helmet doesn't deserve to be mentioned. NVCR didn't even strike in his mind while he used so many different words to express his need for a viable gbm therapy. He gave all the clue mentioning immunotherapy. Which immunotherapy survived todate at Phase 3 clinical trial level? The shorts are clueless here. Glad smart LP is taking them blindfolded to a place of no return.